CURE Pharmaceutical Revenue and Competitors
Estimated Revenue & Valuation
- CURE Pharmaceutical's estimated annual revenue is currently $15.3M per year.
- CURE Pharmaceutical's estimated revenue per employee is $299,382
- CURE Pharmaceutical's total funding is $29M.
Employee Data
- CURE Pharmaceutical has 51 Employees.
- CURE Pharmaceutical grew their employee count by 42% last year.
CURE Pharmaceutical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Accounting Officer | Reveal Email/Phone |
2 | CEO Cure | Reveal Email/Phone |
3 | Chief Business Officer | Reveal Email/Phone |
4 | Chief Scientific Officer | Reveal Email/Phone |
5 | Chief Operating Officer | Reveal Email/Phone |
CURE Pharmaceutical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.1M | 33 | -40% | N/A | N/A |
#2 | $47.6M | 164 | 20% | $20M | N/A |
#3 | $37.3M | 138 | -3% | N/A | N/A |
#4 | $10.1M | 49 | 0% | $175.5M | N/A |
#5 | $45.1M | 152 | -3% | N/A | N/A |
#6 | $23.8M | 88 | 9% | N/A | N/A |
#7 | $12.6M | 52 | -5% | N/A | N/A |
#8 | $86.5M | 298 | 0% | $12.3M | N/A |
#9 | $2.4M | 15 | -12% | N/A | N/A |
#10 | $15.3M | 51 | 42% | $29M | N/A |
What Is CURE Pharmaceutical?
CURE Pharmaceutical is an innovative drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has an industry leading full-service cGMP manufacturing facility and is a preeminent developer and manufacturer of a patented and proprietary delivery system (CureFilm?), the most advanced oral thin film on the market today. CURE has developed an array of products in cutting-edge delivery platforms and partners with leading pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel and Germany, among other markets. Our mission is to improve people's lives by redefining how medicines are delivered and experienced.
keywords:N/A
$29M
Total Funding
51
Number of Employees
$15.3M
Revenue (est)
42%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CURE Pharmaceutical News
Cure Pharmaceutical Holding Corp (CURR) stock has risen 30.43% over the past week and gets a Bullish rating from InvestorsObserver Sentiment...
The market has been down on Cure Pharmaceutical Holding Corp (CURR) stock recently. CURR gets a Bearish score from InvestorsObserver Stock...
Additionally, Cure Pharmaceutical Holding Corp scored a 6 in the Healthcare sector, ranking it higher than 6% of stocks in that sector. Overall...
OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holdings (OTC: CURR), a developer and manufacturer of innovative delivery formulations for drugs, supplements and wellness products, today announced that it has received the first tranche of $4 million of a committed financing of $10 million, ...
Other Companies in Oxnard
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.7M | 52 | -2% | N/A |
#2 | $10.7M | 53 | 4% | N/A |
#3 | $13.7M | 53 | -2% | N/A |
#4 | $10.5M | 53 | -2% | N/A |
#5 | $7.8M | 54 | 42% | N/A |